Implantable medical arrangement employing cardiac power optimization
The implantable medical arrangement with integrated sensors and processors optimizes cardiac power by correlating cardiac electric and mechanical data, addressing the limitations of existing pacing systems by enhancing cardiac output and preventing heart failure through real-time monitoring and closed-loop control.
Patent Information
- Application Number
- PCT/EP2024/062202
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-27
- Filing Date
- 2024-05-03
- Publication Date
- 2024-11-28
AI Technical Summary
Current pacing systems, including those for cardiac resynchronization therapy, fail to effectively optimize cardiac power in patients with pacing-induced heart failure or reduced left ventricular ejection fraction, as they only adjust parameters based on cardiac electrical changes during follow-ups, neglecting mechanical and acoustic data.
An implantable medical arrangement with a detection unit, sensors (such as phonocardiographs and acceleration sensors), and a processor that correlates cardiac electric signals with mechanical and acoustic data to estimate cardiac power parameters like left ventricular ejection fraction and cardiac output, enabling real-time monitoring and closed-loop control of pacing parameters to enhance cardiac power.
This approach allows for precise optimization of cardiac power by directly correlating electric and mechanical events, potentially increasing cardiac output by 10% to 60% and preventing pacing-induced heart failure, offering a more reliable and standardized method compared to external phonocardiography.
Smart Images

Figure EP2024062202_28112024_PF_FP_ABST
Abstract
Description
[0001] IMPLANTABLE MEDICAL ARRANGEMENT EMPLOYING CARDIAC POWER OPTIMIZATION
[0002] The present disclosure generally relates to an implantable medical arrangement for detecting cardiac signals and additional physiologic signals of a patient. This implantable medical arrangement allows for estimating cardiac power of the patient and optionally for optimizing the cardiac power of the patient in response to a cardiac stimulation such as cardiac pacing. The present disclosure further relates to a method for operating an implantable medical arrangement and to a medical method for optimizing a cardiac power parameter of a patient in need thereof.
[0003] Suboptimal right ventricular pacing (RVP), His bundle pacing (HBP) and conduction system pacing (such as left bundle branch pacing (LBBP) or left bundle branch area pacing LBB AP) has been shown to impair left ventricular ejection fraction (LVEF) and reduce cardiac output (CO). Early identification of left ventricular systolic dysfunction (LVSD) is critical in managing pacing-induced heart failure and preventing unfavorable cardiovascular events.
[0004] Currently, the various pacing systems including devices for cardiac resynchronization therapy (CRT) only adjust the pacing parameters in response to the cardiac electrical system changes during regular follow-ups.
[0005] It is an object of the present invention to provide systems and methods suitable for increasing cardiac power, in particular in patients suffering from various forms of degenerative cardiac disease, such as pacing-induced heart failure or pacing-induced reduction in LVEF.
[0006] This object is achieved with an implantable medical arrangement having the features explained in the following. Such an implantable medical arrangement comprises a detection unit, at least one implantable medical sensor, and a processor. The detection unit is configured to detect an electric signal of a heart of a human or animal patient. The detection unit can also be referred to as sensing unit.
[0007] The at least one implantable medical sensor is configured to detect additional physiologic data of the same patient. In this context, the at least one implantable medical sensor is chosen from the group consisting of an acoustic sensor configured to detect acoustic signals of the same heart and an acceleration sensor configured to detect respiratory data of the same patient. Thus, the at least one implantable medical sensor provides additional physiologic data that supplements the electric signals detected by the detection unit.
[0008] The detection unit and the at least one implantable medical sensor are operatively coupled with the processor. Thus, detection unit, the at least one implantable medical sensor, and the processor for a network. Therefore, the implantable medical arrangement can also be denoted as network implant or as networked sensors. The processor is configured to evaluate the electric signal detected by the detection unit and the physiologic data detected by the at least one implantable medical sensor.
[0009] In contrast to prior art solutions, the implantable medical arrangement provides for detecting additional physiologic data of the patient and for evaluating this additional physiologic data together with the cardiac electric signal detected by the detection unit. In doing so, the implantable medical arrangement is able to directly correlate cardiac electric events with resulting cardiac mechanic events and thus, finally, cardiac power.
[0010] The implantable medical arrangement enables the simultaneous monitoring of cardiac electric activity and cardiac mechanic activity and can output the respective data to a physician or other medical staff. The data can then be used as original data for making decisions on future cardiac therapy of the patient. The data can also be used for simply documenting the patient’s cardiac state over time. This may facilitate identifying any newly occurring cardiac dysfunctions or cardiac diseases of the patient. In an embodiment, the acoustic sensor configured to detect acoustic signals of the patient’s heart is a phonocardiograph. Such a phonocardiograph is a device for recording a phonocardiogram (PCG). Recording a phonocardiogram with a phonocardiograph is called phonocardiography. Phonocardiography is an established method for obtaining recordings of cardiovascular sound, that is, an acoustic phenomenon perceivable by auscultation at the cardiac region on the chest wall. Essentially, vibrations of the chest surface are observed that are generated in cardiac structures and transmitted outward towards to the chest wall. Normal heart sounds are initiated by valve closing (the first and the second sound, namely SI and S2) or by filling phenomena (the third and the fourth sound, namely, S3 and S4); besides the normal ones additionally pathological sounds could also exist, for example, generated at opening of degenerated valves, tricuspid regurgitation and mitral regurgitation.
[0011] An implantable medical arrangement comprising an implantable phonocardiograph is significant more sensitive than an approach in which an implantable medical device for detecting and / or stimulating a patient’s heart is combined with externally recorded phonocardiography data (e.g., by an external auscultation). Rather, an external phonocardiography or auscultation has a low diagnostic sensitivity and accuracy since it depends on a combination of location of the applied sensors or the auditory location, human limitations, accepted clinical evidence, and widespread skill discrepancy among various uses. In contrast, an embodiment of the presently claimed implantable medical arrangement comprising a phonocardiograph as implantable acoustic sensor provides a standardized, reliable and consistent possibility of obtaining relevant physiologic data that turned out to be particularly helpful for assessing the patient’s cardiac power.
[0012] Phonocardiography also provides respiratory data, however on an indirect basis, namely on the basis of the patient’s cardiac mechanic activity. An acceleration sensor is able to directly detect respiratory data on the basis of chest movements of the patient. Even such respiratory data is not directly indicative for mechanic movements of the patient’s heart, it also gives a good indication on the patient’s cardiac power. In an embodiment, the detection unit, the implantable medical sensor, and the processor are arranged within a single housing of a single implantable medical device. In this embodiment, the implantable medical device is typically the main component of the implantable medical arrangement. It may be the only component of the implantable medical arrangement. Such a compact design of the implantable medical device with integrated implantable medical sensor(s) makes an implantation of the implantable medical device particularly easy. However, it somehow limits the possible implantation sites. This should be kept in mind since an optimal implantation site of the detection unit may be different from an optimal implantation site of the at least one implantable medical sensor.
[0013] In an embodiment, the detection unit is arranged within a housing of the implantable medical device. Additionally, the implantable medical sensor is configured as a separate device distinct from the implantable medical device. In such a case, two different devices need to be implanted upon implantation of the implantable medical arrangement. However, optimal implantation sites of the detection unit and of the at least one implantable medical sensor can be easier found than in case of an implantable medical device integrating the detection unit, the at least one implantable medical sensor, and the processor.
[0014] In an embodiment, the processor is arranged within the housing of the implantable medical device even in case that the implantable medical sensor is configured as a separate device. Then, the implantable medical device is operatively coupled with the processor. This can be done via a lead such as an electrically conductive lead, or - for many applications even more appropriate - in a wireless manner. In the latter case, the at least one implantable medical sensor comprises a data communication unit that enables a communication with (in particular a data transfer to) the processor.
[0015] All standard data transmission protocols or specifications are appropriate for such a wireless data communication. Examples of standard data transmission protocols or specifications are the Medical Device Radiocommunications Service (MICS), the Bluetooth Low Energy (BLE) protocol, the Zigbee specification, the long range wide area network (LoRaWAN) protocol, the wireless personal area network (WPAN) specification, the low-power wide- area network (LPWAN) specification, the wireless local area network (WLAN) specification, the Global System for Mobile Communications (GSM) specification, the Long-Term Evolution (LTE) standard, and the fifth-generation technology standard for broadband cellular networks (5G).
[0016] In an embodiment, the implantable medical device is an implantable pulse generator (IPG), an implantable cardioverter-defibrillator (ICD), a device for cardiac resynchronization therapy (CRT), or an implantable cardiac monitor. An appropriate cardiac monitor is a loop recorder.
[0017] In an embodiment, the implantable medical sensor is located, in its implanted state, subcutaneously closely above the patient’s heart. Then, heart sounds can be particularly well detected by the implantable medical sensor. If the implantable medical sensor is integrated into the implantable medical device, the implantable medical device itself is, in this embodiment, located, in its implanted state, subcutaneously above the patient’s heart. Generally, the implantable medical sensor can be located anywhere within the patient’s body where it can well measure heart sounds or, alternatively, respiratory movements.
[0018] In an embodiment, the implantable medical device further comprises a memory unit, wherein the memory unit comprises a computer-readable program that causes the processor to perform the steps explained in the following when executed on the processor. In a first step, the electric signal of the patient’ s heart is gathered with the detection unit. This electric signal can be, e.g., an electrocardiogram (ECG) or an intracardiac electrocardiogram (IEGM). At the same time, the additional physiologic data of the patient is gathered with the implantable medical sensor. During or after gathering (or obtaining) the electric signal and the additional physiologic data of the patient, a cardiac power parameter of the patient is estimated by a correlation of the electric signal of the heart of the patient and the additional physiologic data of the patient. This correlation is done by the processor of the implantable medical device. The cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction (LVEF), stroke volume, right ventricular ejection fraction and cardiac output (CO). In an embodiment, the estimated cardiac power parameter is output by the implantable medical arrangement. This can be done, e.g., by providing the estimated cardiac power parameter (and optionally additional data such as the electric signal of the patient’s heart and the additional physiologic data of the patient) to a remote service center. For this purpose, the implantable medical arrangement comprises, in an embodiment, a data communication unit that allows such data communication with a remote service center. The communication can be performed in a wireless manner by any of the communication standards and protocols that have already been explained above with respect to a wireless communication between the at least one implantable medical sensor and the implantable medical device.
[0019] In an embodiment, the implantable medical device further comprises a stimulation unit configured to stimulate the patient’s heart. In this embodiment, the computer-readable program causes the processor to additionally perform a further step, after having estimated the cardiac power parameter. This further step comprises amending pacing parameters of the stimulation to be applied by the stimulation unit to optimize the cardiac power parameter of the patient. By this additional method step, a closed-loop control of the implantable medical arrangement is established that alters or updates at least one pacing parameter of the stimulation unit to improve the cardiac power parameter. Due to this closed-loop control system, the beat-to-beat variety of the cardiac power parameter can be assessed and directly addressed by amending the at least one pacing parameter. This closed-loop control system is particularly helpful within the relatively new areas of His bundle pacing and conduction system pacing since an interaction of the cardiac power parameter with the applied pacing parameters is yet widely unknown. The closed-loop control system does not require the predevelopment of such an interaction. Rather, it directly determines such interaction on a beat- to-beat basis and is able to address any undesired decrease of cardiac power by amending the at least one pacing parameter. In doing so, the physiological characteristics of the respective patient are inherently considered. Thus, the closed-loop control system does not require individualized estimations of the effect of an amended pacing parameter, but directly measures such effect and can thus optimize the cardiac output parameter of the patient in a particularly appropriate manner. Since an iterative optimization of the cardiac power parameter of the patient is particularly helpful, the computer-readable program causes the processor, in an embodiment, to perform another method step, namely repeating, after having performed a stimulation of the heart of the patient with the at least one amended pacing parameter the steps of gathering the electric signal of the heart of the patient, of gathering the additional physiologic data of the patient and of estimation of the cardiac power parameter of the patient to optimize the cardiac power parameter of the patient. Optionally, also the step of amending the at least one pacing parameter is repeated. The repetition takes place until a predetermined minimum optimization of the cardiac power parameter of the patient is achieved. In an embodiment, this predetermined minimum optimization is an increase of the initially estimated cardiac power parameter by at least 10 % to 100 %, in particular at least 20 % to 90 %, in particular at least 30 % to 80 %, in particular at least 40 % to 70 %, in particular at least 50 % to 60 %.
[0020] In an embodiment, estimating the cardiac power parameter involves calculating an electromechanical activation time (EMAT). In this context, the electromechanical activation time is a time interval from the onset of the QRS complex in the electric signal of the patient’s heart to the first heart sound (SI) caused by closure of the cardiac valve. This duration of time represents the time required by the left ventricular systole to produce sufficient pressure to close the mitral valve and is related to the acceleration of left ventricular pressure. In patients with prolonged EMAT, it has been demonstrated that this increased duration is associated with left ventricular systolic dysfunction (LVSD), while shorter EMAT was associated with improved left ventricular contractility and shortened electromechanical delay. This embodiment is particularly well suited for measuring and adapting the duration of the EMAT to improve LVEF and / or CO and to reduce LVSD.
[0021] In an embodiment, optimizing the cardiac power parameter of the patient includes amending the EMAT, in particular shortening the EMAT by choosing appropriate pacing parameters for the next stimulation cycle.
[0022] In an aspect, the present invention relates to a method for operating an implantable medical arrangement, in particular an implantable medical arrangement according to the preceding explanations. In this context, the method comprises the steps explained in the following. In a first step, the electric signal of the patient’s heart is gathered with a detection unit of the implantable medical arrangement. This electric signal can be, e.g., an electrocardiogram (ECG) or an intracardiac electrocardiogram (IEGM). At the same time, additional physiologic data of the patient is gathered with an implantable medical sensor of the implantable medical arrangement. During or after gathering (or obtaining) the electric signal and the additional physiologic data of the patient, a cardiac power parameter of the patient is estimated by a correlation of the electric signal of the heart of the patient and the additional physiologic data of the patient. This correlation is done by a processor of the implantable medical arrangement. The cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction (LVEF) and cardiac output (CO).
[0023] In an embodiment, at least one pacing parameter of a stimulation to be applied by a stimulation unit of the implantable medical arrangement is amended to optimize the cardiac power parameter of the patient. By this additional method step, a closed-loop control of the implantable medical arrangement is established that alters or updates at least one pacing parameter of the stimulation unit to improve the cardiac power parameter.
[0024] In an embodiment, the steps of gathering the electric signal of the heart of the patient, of gathering the additional physiologic data of the patient and of estimation of the cardiac power parameter of the patient to optimize the cardiac power parameter of the patient are repeated after having performed a stimulation of the heart of the patient with the at least one amended pacing parameter. Optionally, also the step of amending the at least one pacing parameter is repeated. The repetition takes place until a predetermined minimum optimization of the cardiac power parameter of the patient is achieved. In an embodiment, this predetermined minimum optimization is an increase of the initially estimated cardiac power parameter by at least 10 % to 100 %, in particular at least 20 % to 90 %, in particular at least 30 % to 80 %, in particular at least 40 % to 70 %, in particular at least 50 % to 60 %.
[0025] In an aspect, the present invention relates to a method for optimizing a cardiac power parameter of the patient in need thereof. This method is particularly carried out using an implantable medical arrangement according to the preceding explanations. The method comprises the steps explained in the following.
[0026] In a first step, the electric signal of the patient’s heart is gathered with a detection unit of the implantable medical arrangement. This electric signal can be, e.g., an electrocardiogram (ECG) or an intracardiac electrocardiogram (IEGM). At the same time, additional physiologic data of the patient is gathered with an implantable medical sensor of the implantable medical arrangement. During or after gathering (or obtaining) the electric signal and the additional physiologic data of the patient, a cardiac power parameter of the patient is estimated by a correlation of the electric signal of the heart of the patient and the additional physiologic data of the patient. This correlation is done by a processor of the implantable medical arrangement. The cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction (LVEF) and cardiac output (CO).
[0027] Afterwards, at least one pacing parameter of a stimulation to be applied by a stimulation unit of the implantable medical arrangement is amended to optimize the cardiac power parameter of the patient. By this additional method step, a closed-loop control of the implantable medical arrangement is established that alters or updates at least one pacing parameter of the stimulation unit to improve the cardiac power parameter.
[0028] Subsequently, the heart of the patient is stimulated applying the at least one amended pacing parameter.
[0029] In an embodiment, the steps of gathering the electric signal of the heart of the patient, of gathering the additional physiologic data of the patient and of estimation of the cardiac power parameter of the patient to optimize the cardiac power parameter of the patient are repeated after having performed a stimulation of the heart of the patient with the at least one amended pacing parameter. Optionally, also the step of amending the at least one pacing parameter and the step of stimulating the patient’s heart with the amended pacing parameter are repeated. The repetition takes place until a predetermined minimum optimization of the cardiac power parameter of the patient is achieved. In an embodiment, this predetermined minimum optimization is an increase of the initially estimated cardiac power parameter by at least 10 % to 100 %, in particular at least 20 % to 90 %, in particular at least 30 % to 80 %, in particular at least 40 % to 70 %, in particular at least 50 % to 60 %.
[0030] All embodiments of the implantable medical arrangement can be combined in any desired way and can be transferred either individually or in any arbitrary combination to any of the described methods. Likewise, all embodiments of the described methods can be combined in any desired way and can be transferred either individually or in any arbitrary combination to the implantable medical arrangement or to the respective other method.
[0031] The various features and advantages of the present invention may be more readily understood with reference to the following detailed description and the embodiments shown in the drawings. Herein,
[0032] Fig. 1 A schematically shows an embodiment of an implantable medical arrangement;
[0033] Fig. IB schematically illustrates various components of an implantable medical device forming part of the implantable medical arrangement of Figure 1A; and
[0034] Fig. 2 schematically illustrates an embodiment of a closed-loop control method applied by the implantable medical arrangement shown in Figures 1 A and IB.
[0035] Subsequently, embodiments of the invention shall be described in detail with reference to the drawings. In the drawings, like reference numerals designate like structural elements.
[0036] It is to be noted that the embodiments are not limiting for the invention, but merely represent illustrative examples.
[0037] Figure 1 A schematically shows a patient 1 to whom a system 2 is implanted that comprises a device 3 for cardiac resynchronization therapy (CRT) as well as a first phonocardiograph 4, a second phonocardiograph 5, and a third phonocardiograph of 6. The system 2 serves as implantable medical arrangement. The CRT device 3 serves as implantable medical device that comprises, amongst others, a detection unit for detecting an electric signal of a heart 7 of the patient 1 (confer Figure IB for details).
[0038] The first phonocardiograph 4, the second phonocardiograph 5, and the third phonocardiograph 6 represent implantable medical sensors and are able to detect acoustic signals of the patient’s heart 7. For this purpose, the first phonocardiograph 4 and the second phonocardiograph 5 are implanted subcutaneously directly above the patient’s heart 7. The third phonocardiograph 6 is subcutaneously implanted in the region of the fifth intercostal space of the patient 1. Also in this location, the third phonocardiograph 6 is able to detect sounds of the patient’s heart 7. The first phonocardiograph 4, the second phonocardiograph 5, and the third phonocardiograph 6 are implanted in different orientations to detect cardiac acoustic signals in a highly reliable manner.
[0039] The first phonocardiograph 4, the second phonocardiograph 5, and the third phonocardiograph 6 are operatively coupled with the CRT device 3 so as to form the system 2. This operative coupling enables the first phonocardiograph 4, the second phonocardiograph 5, and the third phonocardiograph 6 to transmit signals relating to detected cardiac sounds of the patient’s heart 7 to the CRT device 3. Thus, the system 2 represents a network comprising the CRT device 3 and the first phonocardiograph 4, the second phonocardiograph 5, and third phonocardiograph 6. The CRT device 3 and the three phonocardiographs 4, 5, 6 stand in a master / slave relationship, wherein the CRT device 3 takes over the master functionalities.
[0040] The system 2 collects electric signals and acoustic signals of the patient’s heart 7. By correlating these electric signals and acoustic signals, the left ventricular ejection fraction as well as the cardiac output of the patient’s heart 7 can be estimated. Thus, it is possible to estimate cardiac power parameters and to thus indicate the efficacy of a stimulation of the patient’s heart 7 provided by the CRT device 3. By adjusting the pacing parameters applied by the CRT device 3, an optimization of these cardiac power parameters is made possible.
[0041] Due to this internal control of the CRT device 3 by the data provided by the three phonocardiographs 4, 5, 6, a closed-loop control system is established that enables a highly reliable individual adaptation of the pacing parameters applied by the CRT device 3 without any temporal delay like in case of gathering data with different devices and submitting them to an external evaluation unit.
[0042] Figure IB illustrates the main components of the CRT device 3, i.e., a detection unit 31, a stimulation unit 32, a processor 33, and a memory unit 34. The processor 33 is operatively coupled with the detection unit 31, the stimulation unit 32, and the memory unit 34.
[0043] The detection unit 31 is configured to detect an electric signal of the patient’s heart 7. The stimulation unit 32 is configured to stimulate the patient’s heart 7. Typically, the detection unit 31 and the stimulation unit 32 are equipped with the same electrode comprising a plurality of electrode poles that are arranged at or within the patient’s heart 7 so as to be able to detect electric signals of the patient’s heart 7 and to provide pacing pulses for stimulation of the patient’s heart 7.
[0044] Figure 2 schematically illustrates a closed-loop control system established by the system 2 illustrated in Figures 1A and IB. Figure 2 will now be described in the context of Figures 1A and IB. This will be done by making reference to elements illustrated in Figures 1 A and IB.
[0045] In a stimulation step 21, the patient’s heart 7 is stimulated with a predefined set of pacing parameters. This stimulation 21 is carried out by the stimulation unit 32 of the CRT device 3 forming part of the network system 2.
[0046] The stimulation 21 effects an electric activity 22 of the patient’s heart 7 that, in turn, results in a mechanic action 23 of the patient’s heart 7. The electric activity 22 as well as other electric signals of the patient’s heart 7 are detected in an electric detection step 24 by the detection unit 31 of the CRT device 3. Likewise, the mechanic activities of the patient’s heart 7 are detected by the three phonocardiographs 4, 5, 6 in an acoustic detection step 25. Typically, the electric detection step 24 and the acoustic detection step 25 are performed at the same time. They result in signals representing the electric activity and the mechanic activity of the patient’s heart 7. These signals are provided to the processor 33 of the CRT device 3 and are used to estimate the cardiac power parameters such as the left ventricular ejection fraction and / or the cardiac output in an estimation step 26.
[0047] Considering the initially applied pacing parameters in the stimulation step 21 and the resulting cardiac power parameter obtained in the estimation step 26, an optimized set of pacing parameters is generated in an optimization step 27. These optimized pacing parameters are then fed to the stimulation unit 32 so that the next stimulation step 21 can be performed under application of the optimized pacing parameters. Consequently, a closed- loop control system is set up. This closed-loop control system can continuously monitor the cardiac power parameters after each pacing or in other periodic intervals and can provide the required input to change the pacing parameters. This will result in an optimized pacing effecting an optimized cardiac power of the patient 1. The closed-loop control system prevents further deterioration of the patient’s cardiac condition and also prevents hospitalization due to heart failure.
Claims
Claims1. An implantable medical arrangement (2), comprising: a detection unit (31) configured to detect an electric signal of a heart (7) of a human or animal patient (1); at least one implantable medical sensor (4, 5, 6) configured to detect physiologic data of the same patient (1), wherein the at least one implantable medical sensor (4, 5, 6) is chosen from the group consisting of an acoustic sensor configured to detect acoustic signals of the same heart (7) and an acceleration sensor configured to detect respiration data of the same patient (1); and a processor (33) configured to evaluate the electric signal detected by the detection unit (31) and the physiologic data detected by the at least one implantable medical sensor (4, 5, 6).
2. The implantable medical arrangement according to claim 1 , wherein the detection unit (31), the at least one implantable medical sensor (4, 5, 6), and the processor (33) are arranged within a single housing of a single implantable medical device (3).
3. The implantable medical arrangement according to claim 1 , wherein the detection unit (31) is arranged within a housing of an implantable medical device (3) and wherein the at least one implantable medical sensor (4, 5, 6) is configured as a separate device distinct from the implantable medical device (3).
4. The implantable medical arrangement according to claim 3, wherein the processor is (33) arranged within the housing of the implantable medical device (3) and wherein the implantable medical sensor (4, 5, 6) is operatively coupled with the processor (33).
5. The implantable medical arrangement according to any of the preceding claims, wherein the at least one implantable medical sensor (4, 5, 6) is located, in its implanted state, subcutaneously above the heart (7) of the patient (1).
6. The implantable medical arrangement according to any of the preceding claims, wherein the implantable medical device (3) further comprises a memory unit (34), wherein the memory unit (34) comprises a computer-readable program that causes the processor (33) to perform the following steps when executed on the processor (33): a) gathering (24), with the detection unit (31), the electric signal of the heart (7) of the patient (1); b) gathering (25), with the at least one implantable medical sensor (4, 5, 6), the physiologic data of the patient (1); and c) estimating (26) a cardiac power parameter of the patient (1) by a correlation of the electric signal of the heart (7) of the patient (1) and the physiologic data of the patient (1), wherein the cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction, stroke volume, right ventricular ejection fraction and cardiac output.
7. The implantable medical arrangement according to claim 6, wherein the implantable medical device (3) further comprises a stimulation unit (32) configured to stimulate the same heart (7), wherein the computer-readable program causes the processor (33) to additionally perform the following step after step c): d) amending (27) at least one pacing parameter of a stimulation to be applied by the stimulation unit (32) to optimize the cardiac power parameter of the patient (1).
8. The implantable medical arrangement according to claim 7, wherein the computer- readable program causes the processor (33) to additionally perform the following step after step d): e) repeating, after having performed a stimulation of the heart (7) of the patient (1) with the amended at least one pacing parameter, steps a) to c) and optionally step d) to optimize the cardiac power parameter of the patient (1) until a predeterminable minimum optimization of the cardiac power parameter of the patient (1) is achieved.
9. The implantable medical arrangement according to any of claims 6 to 8, wherein estimating the cardiac power parameter involves calculating an electromechanical activation time, the electromechanical activation time being a time interval from an onset of a QRS complex in the electric signal of the heart (7) of the patient (1) to a first heart sound caused by closure of a cardiac valve.
10. A method for operating an implantable medical arrangement, in particular an implantable medical arrangement according to any of the preceding claims, the method comprising the following steps: a) gathering (24), with a detection unit (31) of the implantable medical arrangement (2), an electric signal of a heart (7) of a patient (1); b) gathering (25), with an implantable medical sensor (4, 5, 6) of the implantable medical arrangement (2), physiologic data of the same patient (1); and c) estimating (26), with a processor (33) of the implantable medical arrangement (2), a cardiac power parameter of the patient (1) by a correlation of the electric signal of the heart (7) of the patient (1) and the physiologic data of the patient (1), wherein the cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction and cardiac output.
11. The method according to claim 10, the method comprising the following step after step c): d) amending (27) at least one pacing parameter of a stimulation to be applied by a stimulation unit (32) of the implantable medical arrangement (2) to optimize the cardiac power parameter of the patient (1).
12. The method according to claim 11, the method comprising the following step after step d): e) repeating, after having performed a stimulation of the heart (7) of the patient (1) with the amended at least one pacing parameter, steps a) to c) and optionally step d) to optimize the cardiac power parameter of thepatient (1) until a predeterminable minimum optimization of the cardiac power parameter of the patient (1) is achieved.
13. A method for optimizing a cardiac power parameter of a patient in need thereof, in particular using an implantable medical arrangement according to any of claims 1 to 9, the method comprising the following steps: a) gathering (24), with a detection unit (31) of an implantable medical arrangement (2), an electric signal of a heart (7) of the patient (1); b) gathering (25), with an implantable medical sensor (4, 5, 6) of the implantable medical arrangement (2), physiologic data of the patient (1); c) estimating (26), with a processor (33) of the implantable medical arrangement (2), a cardiac power parameter of the patient (1) by a correlation of the electric signal of the heart (7) of the patient (1) and the physiologic data of the patient (1), wherein the cardiac power parameter is chosen from the group consisting of left ventricular ejection fraction and cardiac output; d) amending (27) at least one pacing parameter of a stimulation to be applied by a stimulation unit (32) of the implantable medical arrangement (2) to optimize the cardiac power parameter of the patient (1); and e) stimulating (21) the heart (7) of the patient (1) with the amended at least one pacing parameter.
14. The method according to claim 13, the method comprising the following step after step d): e) repeating steps a) to c) and optionally steps d) and e) to optimize the cardiac power parameter of the patient (1) until a predeterminable minimum optimization of the cardiac power parameter of the patient (1) is achieved.
Citation Information
Patent Citations
Active implantable medical device with biventricular pacing and automatic optimization of pacing configuration
US20060293715A1
Techniques for mitigating motion artifacts from implantable physiological sensors
US20130197597A1
Pacing-based hypertension therapy pacing rate adjustment
US20190299004A1
Methods of automatically optimizing AV delay by way of monitoring the heart sound
US7079896B1
